Coming Off an Antidepressant: Withdrawal, Relapse, and Tapering Safely
Many people can stop an antidepressant successfully, but how they stop matters. Stopping suddenly or over just a couple of weeks raises the chance of withdrawal symptoms and of depression coming back. A slow, gradual taper, planned with a prescriber and paired with support, gives the best odds.
Is It the Right Time?
Coming off an antidepressant is a reasonable goal for many people who have been well for a while. A recent analysis of 76 trials found that a slow taper combined with psychological support prevented relapse about as well as staying on the medication. Abrupt or fast stopping did worse.
It may be worth waiting if you:
Recovered recently, usually within the past 6 to 12 months
Are going through a major life change, loss or stressful stretch
Are pregnant or planning a pregnancy (talk with your prescriber first)
In a large primary care trial, more people relapsed within a year after stopping than after continuing (56% vs 39%). But nearly half of those who stopped stayed well. The goal is to find out, carefully, which group you are likely to be in.
How Common Is Withdrawal?
Estimates vary widely, and researchers disagree about them. One large review found that about 31% of people had at least one withdrawal symptom after stopping an antidepressant, compared with 17% after stopping a placebo. Severe symptoms affected about 3%. Other researchers argue the true rate is higher, especially after long-term use.
What is clear: withdrawal is more likely after longer use and higher doses, and with some medications. Paroxetine and venlafaxine are linked to withdrawal more often than others.
Common symptoms include:
Brief "electric shock" sensations, often called brain zaps
Nausea or flu-like feelings
Trouble sleeping or vivid dreams
Irritability, anxiety or tearfulness
Feeling unsteady or "off"
Withdrawal or Relapse?
Telling the two apart is the most important part of a taper. Mistaking withdrawal for relapse can keep someone on a medication they no longer need. Mistaking relapse for withdrawal can delay needed treatment.
Medication withdrawal
When it starts: usually within days of a dose change
What it feels like: often physical and new: dizziness, brain zaps, nausea
If the dose is held or slightly raised: often eases within days
Relapse of symptoms
When it starts: usually weeks to months later
What it feels like: usually the original symptoms returning
If the dose is held or slightly raised: improves more slowly, if at all
These are patterns, not rules. Withdrawal can sometimes start late or last longer, and the two can overlap. That is why check-ins during a taper matter.
What a Careful Taper Looks Like
Older guidance suggested cutting the dose in half for two weeks and then stopping. For many people, that is too fast.
Newer approaches, including the Maudsley Deprescribing Guidelines, use proportional (hyperbolic) tapering. Each step reduces the dose by a percentage of the current dose, so the steps get smaller as the dose gets lower. The reason is that the last few milligrams of many antidepressants still have a large effect on the brain.
In practice, that means:
Small, steady steps, often a 10% to 25% reduction of the current dose, held for weeks before the next one
Doses that make small steps possible, such as liquid formulations, lower-strength tablets, or compounded doses
Pausing or stepping back if withdrawal symptoms appear, then going more slowly
Support alongside the taper, such as therapy, which improves the odds of staying well
A plan for what to watch for, and who to contact
Many tapers take several months. Some take longer, especially after years of use. Speed is not the goal.
Don't skip doses or switch to every other day as a way to taper. Uneven blood levels can make withdrawal worse.
How Welmivia Can Help
Dr. Diaz helps adults in Virginia and Florida come off psychiatric medications by video, using the Maudsley Deprescribing Guidelines. A first evaluation reviews why the medication was started, how you are doing now, and what happened with any past attempts to stop. You get a written taper plan and follow-up visits at each step. Dr. Diaz can coordinate with your primary care physician or therapist.
Welmivia sees private-pay patients and participates in Original Medicare. We are not able to see patients with Medicare Advantage or Medicaid. For private-pay visits, book an evaluation and mention that you'd like to discuss tapering. With Original Medicare, call 434-623-0003 or use our Medicare request form.
What to Take Away
Many people can stop an antidepressant, and a slow taper with support works best.
Withdrawal usually starts within days of a dose change and eases when the dose is held; relapse comes on later and looks like the original illness.
Plan any change with a prescriber; don't stop suddenly or skip doses.
Welmivia is not a crisis service. If someone is in danger, call 911. For a mental health crisis, call or text 988.
Sources
Zaccoletti D, et al. Comparison of antidepressant deprescribing strategies in individuals with clinically remitted depression: a systematic review and network meta-analysis. Lancet Psychiatry. 2026.
Lewis G, et al. Maintenance or discontinuation of antidepressants in primary care. N Engl J Med. 2021.
Duffy L, et al. Clinical factors associated with relapse in depression in a sample of UK primary care patients who have been on long-term antidepressant treatment. Psychol Med. 2023.
Henssler J, et al. Incidence of antidepressant discontinuation symptoms: a systematic review and meta-analysis. Lancet Psychiatry. 2024.
Kalfas M, et al. Incidence and nature of antidepressant discontinuation symptoms: a systematic review and meta-analysis. JAMA Psychiatry. 2025.
Zhang MM, et al. Incidence and risk factors of antidepressant withdrawal symptoms: a meta-analysis and systematic review. Mol Psychiatry. 2024.
Moncrieff J, et al. Evidence on antidepressant withdrawal: an appraisal and reanalysis of a recent systematic review. Psychol Med. 2025.
Fava GA, et al. Withdrawal symptoms after serotonin-noradrenaline reuptake inhibitor discontinuation: systematic review. Psychother Psychosom. 2018.
Horowitz MA, Taylor D. Tapering of SSRI treatment to mitigate withdrawal symptoms. Lancet Psychiatry. 2019.
Groot PC, van Os J. Successful use of tapering strips for hyperbolic reduction of antidepressant dose: a cohort study. Ther Adv Psychopharmacol. 2021.
Horowitz MA, Taylor D. The Maudsley Deprescribing Guidelines. Wiley; 2024.
This guide is general information, not medical advice for your situation. Do not change any medication without talking with your prescriber.

